Yu Jun Wong is an expert in Gastroenterology at Changi General Hospital (Singapore). As of October 2026, ScienceLeadR ranks Yu Jun Wong in the top 1% of experts worldwide for Varicose Veins, and in the top 1% of experts in Singapore for Hypertension, Portal. Yu Jun Wong has authored 188 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 4 of them ongoing. SLR score: 1,156 (community average: 125). How the SLR is computed.

LeadR Profile

Yu Jun Wong Changi General Hospital Singapore
1 156 ScienceLeadR Reputation 1156
Network Map

Gastroenterology

Subspecialties: Hepatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2026

Source: PubMed

Changi General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 188

Citations

Citations: 2 382 1st author: 58 Last author: 36 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Biochemical Response in Asian Primary Biliary Cholangitis: A Strong Signal, but Not the Whole Story.
PMID 42892755 — cholangitis
J Clin Exp Hepatol20260
Dietary and Nutritional Considerations for Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriasis and Hidradenitis Suppurativa: A Narrative Review.
PMID 42884704 — liver diseases, skin, hidradenitis suppurativa, skin diseases, liver, diet, food, hidradenitis, weight loss, psoriasis, dermatology, food, processed
Nutrients20260
Steatotic liver disease in autoimmune liver disease: Prevalence and clinical impact in a Southeast Asian cohort.
PMID 42872297 — liver diseases, hepatitis, autoimmune, mortality, liver, prevalence, therapeutics
Can Liver J20260
Portal vein thrombosis increases short-term mortality among hospitalized patients with cirrhosis in a global cohort.
PMID 42766768 — liver transplantation, mortality, non-alcoholic fatty liver disease, portal vein, thrombosis, veins, hepatitis
Liver Transpl20260
Characterisation of liver disease using quantitative MRI: report of the imaging arm of the ELEGANCE study.
PMID 42754838 — liver diseases, liver, gastrointestinal diseases, spleen
BMC Gastroenterol20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 8
Phase 2/Phase 3 1
Phase 4 1

By status:

Recruiting 4
Completed 3
Unknown 2
Terminated 1

By type:

Observational 7
Interventional 3

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 0
multicentric5to9 2
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673 — research design, hypertension, safety, fibrosis, hepatitis, chronic, liver, esophageal and gastric varices, endoscopy, hypertension, portal, varicose veins, hepatitis
N/ARecruiting2025
Precision Medicine to Predict the Trajectory of Liver Cirrhosis Prospective Cohort Study
NCT05899309 — diabetes mellitus, research design, laboratories, liver cirrhosis, fibrosis, cohort studies, biopsy, liver, precision medicine, diagnosis, frailty, spleen, metabolic syndrome, liver stiffness
N/ARecruiting2022
Rotational Thromboelastometry (ROTEM ) Guided Transfusion for Elective Procedures in Patients With Cirrhosis (REduCe) An Open Label Randomized Controlled Trial
NCT05698134 — cells, liver transplantation, blood, point-of-care systems, liver cirrhosis, fibrosis, liver, transplants, blood cells, blood platelets, wounds and injuries, plasma, liver failure
N/ARecruiting2021
Gut Microbiome and Metabolome in Patients With Gallstone Disease After Surgical and Endoscopic Interventions
NCT05689255 — bile, gallstones, gallbladder, bile ducts, cohort studies, cholelithiasis, cholecystectomy, bile duct diseases, gastrointestinal microbiome
N/ARecruiting2022

LeadR Networks

Main global connection map